SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer
Clinical trial NCT00361244 · TERMINATED
Trial details
- NCT number
- NCT00361244
- Sponsor
- Massachusetts General Hospital
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Primary completion
- 2007-10-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.